gandotinib   Click here for help

GtoPdb Ligand ID: 7909

Synonyms: LY-2784544 | LY2784544
Immunopharmacology Ligand
Compound class: Synthetic organic
Comment: Gandotinib (LY2784544) is a potent ATP-competitive and selective JAK2 inhibitor [2], with potential clinical value for its ability to inhibit the constitutive activity of the JAK2V617F mutation found in myeloproliferative neoplasms (MPNs).
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 6
Hydrogen bond donors 2
Rotatable bonds 6
Topological polar surface area 83.37
Molecular weight 469.18
XLogP 4.58
No. Lipinski's rules broken 0
Click here for help
Canonical SMILES Clc1ccc(c(c1)F)Cc1c(C)nc2n1nc(Nc1n[nH]c(c1)C)cc2CN1CCOCC1
Isomeric SMILES Clc1ccc(c(c1)F)Cc1c(C)nc2n1nc(Nc1n[nH]c(c1)C)cc2CN1CCOCC1
InChI InChI=1S/C23H25ClFN7O/c1-14-9-21(29-28-14)27-22-11-17(13-31-5-7-33-8-6-31)23-26-15(2)20(32(23)30-22)10-16-3-4-18(24)12-19(16)25/h3-4,9,11-12H,5-8,10,13H2,1-2H3,(H2,27,28,29,30)
Immunopharmacology Comments
Gandotinib is included in GtoImmuPdb because of JAK2's association with inflammatory disease, and because of its effect on myeloproliferative neoplasms.